Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease (COMPASS)

This study is currently recruiting participants. (see Contacts and Locations)

Verified September 2016 by Bayer

Sponsor:

Collaborator:

Hamilton Health Sciences Corporation, Population Health Research Institute

Information provided by (Responsible Party):

Bayer

ClinicalTrials.gov Identifier:

NCT01776424

First received: January 24, 2013

Last updated: September 19, 2016

Last verified: September 2016

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	March 2018
Estimated Primary Completion Date:	February 2018 (Final data collection date for primary outcome measure)